Wellbeing International Foundation

Wellbeing International Foundation researches and delivers Cell-Free Therapy, an autologous regenerative protocol built on the body's own repair signalling.

CFT begins with a single blood draw. The regenerative signalling material in that blood, the growth factors, extracellular vesicles and other signalling proteins that cells use to communicate, is captured, isolated and concentrated in a GMP-certified laboratory in Germany, then banked and returned to the same patient. Nothing foreign is introduced. There are no donor cells and no drugs.

That design is the point. Because the therapy carries no living cells, it carries none of the risks specific to living cells. And because the material is the patient's own, there is nothing to match and nothing to reject.

The approach rests on around twenty years of research and more than fifteen years of clinical experience. A peer-reviewed pilot study of a multi-modal longevity protocol using autologous conditioned media was published in Frontiers in Aging in June 2026, jointly with xLongevity. Eleven white papers, the CFT Advantage Series, set out the science in full and are published openly on our site.

CFT is delivered through a network of licensed clinicians. Individual results vary. CFT is not intended to diagnose, treat, cure, or prevent any disease.